Vidium (12/7/2022)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} {{webinarsregistrationpage::race_approved}} true 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Vidium {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

This webinar will inform veterinary practitioners about the clinical application of cancer genomics in the management of canine lymphoma and mast cell tumors. The presentation will begin with an overview of how to incorporate genomics into daily clinical practice, followed by a review of each cancer type and how genomic findings can expand treatment options for the management of those options. The discussion will conclude with a deep dive into trametinib, the third in Vidium’s series of targeted therapies.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} Become familiar with how to incorporate genomics into daily clinical practice Appreciate the utility of genomic information in the management of canine lymphoma and mast cell tumors Understand the canine-specific information for trametinib {{webinarsregistrationpage::what_youll_learn_bullet_4}} {{webinarsregistrationpage::what_youll_learn_bullet_5}} {{webinarsregistrationpage::what_youll_learn_bullet_6}} {{webinarsregistrationpage::additional_subhead}} {{webinarsregistrationpage::additional_copy}} In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.